CTA FOCUS proudly announces opening of its subsidiary in Moscow, Russia.
Bucharest – Romania, 10th of August 2018
Clinical Trial Agreements FOCUS (CTA FOCUS) proudly announces opening of its subsidiary in Moscow, Russia.
Achieving this milestone CTA FOCUS expanded its presence to the biggest country in the World with over 1600 experienced sites accredited by the Ministry of Health for clinical trials conduct.
The company is now based in Romania with its headquarter in Bucharest, and offices in Kiev, Ukraine in Malaga, Spain and starting from 10th of August will owe the 4th headquarter in one of most promising capitals in the world.
In 2017 Russian Ministry of Health approved over 700 clinical trials and the market has the tendency for growth. Vast population of patients, motivated sites, skilled and experienced investigators located in different parts of the country with the territory of 17 million square meters is now available for CTA FOCUS’s clients.
The Russian division, with registered office at Petrovsky blvd., 3 build. 2, 127051, Moscow, Russia, will be mainly focused on clinical trials negotiation with the secondary focus on site payments.
The Russian market healthcare market raised of the interest of sponsors, CROs all over the world due to its increasing phase, over the last two years more than 31 countries sponsored clinical trials all over Russia and more than 70% of new drugs registered in Europe in were tested in phase II-IV clinical trials in Russia.
High recruitment rates and low costs certainly make it an attractive location. Other advantages of conducting clinical trials in Russia include short enrolment periods due to Russia’s centralized healthcare system, high recruitment rates, an improving regulatory framework, which is becoming more transparent and less arduous for international players, and rapidly developing clinical trial infrastructure.
The company is very glad to announce this new opportunity and is confident that based on his international know-how, strategic alliances will improve the lives of many patients from Russia and will contribute for an increased healthcare system and balanced lifestyle in the forthcoming years
About CTA Focus:
CTA Focus is an international contracting company with significant experience in negotiating clinical contracts in over 57 countries through EMEA, CIS, APAC, North and South America. Led by professionals with vast hands-on experience in both CRO and Clinical Sponsor’s legal departments.
With its global reach, CTA Focus is the best business solution for both pharmaceutical companies and CRO’s facing challenges in contract and budget negotiations.
For more details could you please contact: Elisa Toma – elisa.toma@ctafocus.com